Performance-enhancing drugs.
Pediatric Hematology/Oncology, Cincinnati Children's Hospital, Cincinnati, OH, USA.
Christopher
C
Dandoy
Rani S
RS
Gereige
D000293:Adolescent; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D019587:Dietary Supplements / Q000009:adverse effects; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D058573:Performance-Enhancing Substances / Q000008:administration & dosage / Q000009:adverse effects; D012307:Risk Factors; D015813:Substance Abuse Detection; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D014481:United States / Q000453:epidemiology
D045930:Anabolic Agents; D000697:Central Nervous System Stimulants; D058573:Performance-Enhancing Substances; D019382:Human Growth Hormone